Evexia Lifecare share acquisition: Kiran Kumar Jain now holds 86% after buying 1 lakh shares

What Evexia Lifecare announced

On 19 June 2026, Evexia Lifecare Ltd (BSE: 524444) filed a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing records a share‑purchase by individual acquirer Kiran Kumar Jain M., who increased his holding in the company to 11.00 crore shares, representing 86 % of the total voting capital.

The acquisition was executed on 5 June 2025 through an open‑market purchase. No warrants, convertible securities or other instruments were part of the transaction, and the equity share capital of Evexia Lifecare remained unchanged at Rs 187.73 crore.

Details of the acquisition

• Acquirer: Kiran Kumar Jain M. (PAN: ACHPM2247E) – not part of the promoter group.
• Method: Open‑market purchase (market purchase).
• Date of acquisition: 5 June 2025.
• Shares acquired: 1 00 000 shares (0.1 million), representing a 0.1 % increase in voting rights.
• Pre‑acquisition holding: 10 99 00 000 shares (85 % of voting capital).
• Post‑acquisition holding: 11 00 00 000 shares (86 % of voting capital).
• Equity share capital: Rs 187.73 crore both before and after the transaction; no change in capital structure.
• Other securities: Nil – no pledges, liens, warrants, or convertible instruments were reported.

The filing explicitly states that the acquisition was made “Open Market (Market purchase)” and that “Salient features of the securities acquired” are not applicable, confirming a straightforward cash purchase of equity shares.

Shareholding pattern before and after the transaction

Key facts at a glance

Why this matters for investors

The disclosure satisfies SEBI’s requirement for continuous reporting of substantial share acquisitions. By crossing the 80 % threshold, the acquirer now holds a controlling stake, which may trigger additional regulatory obligations such as a mandatory open offer to minority shareholders under the Takeover Code, should the acquirer wish to increase his stake further. However, the filing does not indicate any intention to launch such an offer.

For existing shareholders, the transaction does not dilute their holdings because the purchase was made on the open market, using shares already issued. The equity capital of the company remains unchanged, and no new securities were issued. Consequently, the immediate financial impact on the balance sheet is limited to the cash outflow by the acquirer, which is not reflected in the company’s accounts.

Investors should monitor any subsequent filings that may disclose a public open offer, shareholder meeting resolutions, or changes in promoter status, as these could affect voting dynamics and corporate governance.

Conclusion

Evexia Lifecare Ltd’s filing on 19 June 2026 confirms that Kiran Kumar Jain M. increased his shareholding to 11 crore shares (86 % of voting rights) through an open‑market purchase on 5 June 2025. The transaction did not alter the company’s equity capital and involved no additional securities. While the acquirer now controls a substantial majority, any further action—such as a mandatory open offer—will require separate regulatory disclosures.

The acquisition brings Kiran Kumar Jain M.’s holding to 86 % of Evexia Lifecare’s voting capital, as disclosed under SEBI Regulation 29(2).